Literature DB >> 15937197

Pulmonary artery thrombosis in a patient with severe acute respiratory syndrome.

K H L Ng1, A K L Wu, V C C Cheng, B S F Tang, C Y Chan, C Y Yung, S H Luk, T W Lee, L Chow, K Y Yuen.   

Abstract

Severe acute respiratory syndrome (SARS) is an emerging infectious disease with both pulmonary and extra-pulmonary manifestations. Although coagulation abnormalities are common in these patients, clinically overt thromboembolic events are rarely reported. This report describes the first case of pulmonary artery thrombosis in a patient with laboratory confirmed SARS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937197      PMCID: PMC1743280          DOI: 10.1136/pgmj.2004.030049

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  39 in total

Review 1.  Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.

Authors:  Vincent C C Cheng; Susanna K P Lau; Patrick C Y Woo; Kwok Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

2.  Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles.

Authors:  Miao-Hsi Hsieh; Nazar Beirag; Valarmathy Murugaiah; Yu-Chi Chou; Wen-Shuo Kuo; Hui-Fang Kao; Taruna Madan; Uday Kishore; Jiu-Yao Wang
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

3.  Fatal Pulmonary Thromboembolism in SARS-CoV-2-Infection.

Authors:  Zachary Grimes; Clare Bryce; Emilia Mia Sordillo; Ronald E Gordon; Jason Reidy; Alberto E Paniz Mondolfi; Mary Fowkes
Journal:  Cardiovasc Pathol       Date:  2020-05-12       Impact factor: 2.185

Review 4.  Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?

Authors:  Vanessa Bianconi; Francesco Violi; Francesca Fallarino; Pasquale Pignatelli; Amirhossein Sahebkar; Matteo Pirro
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

5.  CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2.

Authors:  Razie Amraei; Wenqing Yin; Marc A Napoleon; Ellen L Suder; Jacob Berrigan; Qing Zhao; Judith Olejnik; Kevin Brown Chandler; Chaoshuang Xia; Jared Feldman; Blake M Hauser; Timothy M Caradonna; Aaron G Schmidt; Suryaram Gummuluru; Elke Mühlberger; Vipul Chitalia; Catherine E Costello; Nader Rahimi
Journal:  ACS Cent Sci       Date:  2021-06-30       Impact factor: 18.728

6.  Immunothrombosis in Acute Respiratory Dysfunction of COVID-19.

Authors:  Xiang-Zhi Fang; Ya-Xin Wang; Ji-Qain Xu; Ya-Jun He; Zhe-Kang Peng; You Shang
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

7.  COVID-19 and Acute Pulmonary Embolism in Postpartum Patient.

Authors:  Zohre Khodamoradi; Shahrokh Sadeghi Boogar; Farnaz Kamali Haghighi Shirazi; Pariya Kouhi
Journal:  Emerg Infect Dis       Date:  2020-05-12       Impact factor: 6.883

Review 8.  COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.

Authors:  Wolfgang Miesbach; Michael Makris
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

9.  Right Ventricular Clot in Transit in COVID-19: Implications for the Pulmonary Embolism Response Team.

Authors:  Sanjum S Sethi; Robert Zilinyi; Philip Green; Andrew Eisenberger; Daniel Brodie; Cara Agerstrand; Koji Takeda; Ajay J Kirtane; Sahil A Parikh; Erika B Rosenzweig
Journal:  JACC Case Rep       Date:  2020-05-29

Review 10.  Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review.

Authors:  Jaume Alijotas-Reig; Enrique Esteve-Valverde; Cristina Belizna; Albert Selva-O'Callaghan; Josep Pardos-Gea; Angela Quintana; Arsene Mekinian; Ariadna Anunciacion-Llunell; Francesc Miró-Mur
Journal:  Autoimmun Rev       Date:  2020-05-03       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.